Blog & Media

Your doctor used AI to help make a decision about your care. Did they tell you?

Probably not. And a new JAMA Perspective from Stanford argues that silence may no longer be defensible. Written by Prof. Michelle Mello (Stanford Law), Dr. Danton Char, and Sonnet Xu, "Ethical Obligations to Inform Patients About Use of AI Tools" does something the field has been quietly avoiding: it applies the actual logic of informed consent doctrine to AI deployment in clinical settings, and asks who bears responsibility for telling patients what's happening to them.

AI in your radiology department has been cleared and deployed. Is anyone watching what it does next?

That is the question at the heart of a new consensus paper from the European Society of Radiology, published in Insights into Imaging. Using a modified Delphi procedure involving 16 domain experts, the ESR has produced a set of recommendations on post-market surveillance (PMS) and post-market clinical follow-up (PMCF) for AI medical devices in imaging - and the picture it paints of where the field currently stands is not reassuring.